Driving patient-centric innovation

Autoantibody signatures are meaningfully correlated with disease and provide the predictive power to differentiate between patients, informing critical decisions. Our patented technology provides highly specific and reproducible data with the ability to produce autoantibody signatures. Our services support development of novel solutions for a range of applications—from patient stratification to adverse event prediction to development of companion diagnostics.